Insider · CIK 0001451612
Bruce Booth
Files at KYMR (Kymera Therapeutics, Inc.), VIGL (Vigil Neuroscience, Inc.), SION (Sionna Therapeutics, Inc.). First filing Feb 10, 2025, latest Feb 10, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SION: Sionna Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Sionna Therapeutics, Inc. | $1.1M 60,000 shares | +8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | KYMR Kymera Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jun 26, 2025 |
| Jun 12, 2025 | SION Sionna Therapeutics, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +19,959 | $0.00 | $0 | 19,959 | Jun 16, 2025 |
| May 22, 2025 | VIGL Vigil Neuroscience, Inc. | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 5,000 | May 23, 2025 |
| Mar 3, 2025 | VIGL Vigil Neuroscience, Inc. | AGrant or award Stock Option Award (Right to Buy)derivative | +48,393 | $0.00 | $0 | 48,393 | Mar 4, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | CConversion Common Stockindirect: By Atlas Venture Fund XI, L.P. | +2,886,293 | - | - | 2,886,293 | Feb 10, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | CConversion Common Stockindirect: By Atlas Venture Opportunity Fund II, L.P. | +747,727 | - | - | 747,727 | Feb 10, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Atlas Venture Opportunity Fund II, L.P. | +60,000 | $18.00 | $1.1M | 807,727 | Feb 10, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | CConversion Series Seed convertible preferred stockderivativeindirect: By Atlas Venture Fund XI, L.P. | -1,051,051 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | CConversion Series A convertible preferred stockderivativeindirect: By Atlas Venture Fund XI, L.P. | -1,806,317 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | CConversion Series B convertible preferred stockderivativeindirect: By Atlas Venture Fund XI, L.P. | -1,298,332 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | CConversion Series C convertible preferred stockderivativeindirect: By Atlas Venture Fund XI, L.P. | -61,463 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | CConversion Series C convertible preferred stockderivativeindirect: By Atlas Venture Opportunity Fund II, L.P. | -1,092,504 | $0.00 | $0 | 0 | Feb 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.